TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 221 filers reported holding TRANSMEDICS GROUP INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,253,601 | -75.5% | 22,898 | -62.4% | 0.00% | -77.8% |
| Q2 2023 | $5,111,731 | +44.1% | 60,875 | +29.9% | 0.01% | +28.6% |
| Q1 2023 | $3,547,758 | +63.4% | 46,852 | +33.2% | 0.01% | +75.0% |
| Q4 2022 | $2,171,509 | +202.9% | 35,184 | +105.1% | 0.00% | +100.0% |
| Q3 2022 | $717,000 | +99.7% | 17,157 | +50.3% | 0.00% | +100.0% |
| Q2 2022 | $359,000 | +1.4% | 11,413 | -13.4% | 0.00% | 0.0% |
| Q1 2022 | $354,000 | +51.9% | 13,173 | +7.8% | 0.00% | – |
| Q4 2021 | $233,000 | -52.4% | 12,225 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $490,000 | +16.9% | 14,805 | +17.2% | 0.00% | 0.0% |
| Q2 2021 | $419,000 | -31.6% | 12,629 | -14.5% | 0.00% | 0.0% |
| Q1 2021 | $613,000 | +144.2% | 14,769 | +16.8% | 0.00% | 0.0% |
| Q4 2020 | $251,000 | +52.1% | 12,642 | +5.7% | 0.00% | – |
| Q3 2020 | $165,000 | +44.7% | 11,955 | +88.9% | 0.00% | – |
| Q2 2020 | $114,000 | +35.7% | 6,328 | -9.5% | 0.00% | – |
| Q1 2020 | $84,000 | – | 6,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |